Akut Pankreatitli Hastaya Yaklaşım
Synopsis
Acute pancreatitis (AP) is a broad-spectrum necroinflammatory gastrointestinal disease that frequently leads to hospital admissions, primarily caused by gallstones, alcohol, and idiopathic factors. Its pathogenesis is initiated by the intraacinar premature activation of trypsinogen leading to autodigestion. Clinical diagnosis relies on the Atlanta criteria, requiring at least two of the following: severe epigastric pain radiating to the back, serum amylase or lipase levels elevated over three times the upper limit of normal, and characteristic cross-sectional imaging findings. Mainstay treatment consists of pain management, early individualized fluid resuscitation using isotonic saline or Lactated Ringer's solution, and prompt enteral nutrition to preserve mucosal integrity and suppress bacterial translocation. Routine prophylactic antibiotics are strictly discouraged, and contrast-enhanced CT scans are reserved for diagnostic ambiguity or late complications. Disease severity is monitored via scoring tools such as the revised Atlanta classification and BISAP score. In cases of biliary origin, cholecystectomy must be performed prior to discharge to eliminate recurrent attacks, whereas necrotizing pancreatitis is increasingly managed using minimally invasive endoscopic interventions rather than open surgery.
References
R. Pannala, M. Kidd, and I. M. Modlin, “Acute pancreatitis: a historical perspective,” Pancreas, vol. 38, no. 4, pp. 355–366,2009.
Russo MW, Wei JT, Thiny MT, et al. Digestive and liver diseases statistics 2004. Gastroenterology 2004; 126: 1448-53.
A. F. Peery, E. S. Dellon, J. Lund et al., “Burden of gastrointestinal disease in the United States: 2012 update,” Gastroenterology, vol. 143, no. 5, pp. 1179–1187.e3, 2012.
P. A. Banks, T. L. Bollen, C. Dervenis et al., “Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus,” Gut, vol. 62, no. 1, pp. 102–111, 2013.
Lerch MM, Saluja AK, Rünzi M, et al. Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the opossum. Gastroenterology 1993; 104:853-61.
Zilio MB, Eyff TF, Azeredo-Da-Silva ALF, Bersch VP, Osvaldt AB. A systematic review and meta-analysis of the aetiology of acutepancreatitis. HPB (Oxford) 2019;21:259-67. Epub 2018 Sep 22.
Goodchild G, Chouhan M, Johnson GJ. Practical guide to the management of acute pancreatitis. Frontline Gastroenterol 2019;10:292-9.
Sleisenger and Fordtran's Gastrointestinal and Liver Disease, Tenth Edition 2015;Chapter 58, Acute pancreatitis; scott tenner and William m. Steinberg p:969-993
Carmen-Sanchez R, Uscanga L, Bezaury-Rivas P, et al. Potential harmful effect of iodinated intravenous contrast medium on the clinical course of mild acute pancreatitis. Arch Surg 2000; 135:1280-4.
McMahon CJ. The relative roles of magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound in diagnosis of common bile duct calculi: a critically appraised topic Abdominal imaging 2008;33:69.
Basit H, Ruan GJ, Mukherjee S. Ranson Criteria. StatPearls Treasure Island (FL): StatPearls Publishing; 2019-. 2019 Jul 1.
P. A. Banks, M. L. Freeman, and Practice Parameters Committee of the American College of Gastroenterology, “Practice guidelines in acute pancreatitis,” The American Journal of Gastroenterology, vol. 101, no. 10, pp. 2379–2400, 2006.
V. K. Singh, B. U. Wu, T. L. Bollen et al., “Early systemic inflammatory response syndrome is associated with severe acute pancreatitis,” Clinical Gastroenterology and Hepatology, vol. 7, no. 11, pp. 1247–1251, 2009.
Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174: 331-6.
B. U. Wu, R. S. Johannes, X. Sun, Y. Tabak, D. L. Conwell, and P. A. Banks, “The early prediction of mortality in acute pancreatitis: a large population-based study,” Gut, vol. 57, no. 12, pp. 1698–1703, 2008
Warndorf MG, Kurtzman JT, Bartel MJ, et al.: Early fluid resuscitation reduces morbidity among patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011; 9(8): 705–9.
Tenner S, Baillie J, DeWitt J, et al.: American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013; 108(9): 1400–15; 1416.
Wu BU, Hwang JQ, Gardner TH, et al.: Lactated Ringer’s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011; 9(8): 710–717.e1.
Wittau M, Wagner E, Kaever V, et al. Intraabdominal tissue concen¬tration of ertapenem. J Antimicrob Chemother 2006;57:312-6.
Besselink MG, van Santvoort HC, Buskens E, et al.: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 371(9613): 651–9.
Uhl W, Büchler MW, Malfertheiner P, et al.: A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut. 1999; 45(1): 97–104.
Horibe M, Egi M, Sasaki M, et al.: Continuous Regional Arterial Infusion of Protease Inhibitors for Treatment of Severe Acute Pancreatitis: Systematic Review and Meta-Analysis. Pancreas. 2015; 44(7): 1017–23.
Elmunzer BJ, Scheiman JM, Lehman GA, et al.: A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012; 366(15): 1414–22.
M. C. van Baal, M. G. Besselink, O. J. Bakker et al., “Timing of cholecystectomy after mild biliary pancreatitis: a systematic review,” Annals of Surgery, vol. 255, no. 5, pp. 860–866, 2012.
O. J. Bakker, Y. Issa, H. C. van Santvoort et al., “Treatment options for acute pancreatitis,” Nature Reviews. Gastroenterology & Hepatology, vol. 11, no. 8, pp. 462–469, 2014.
H. C. van Santvoort, M. G. Besselink, O. J. Bakker et al., “A step-up approach or open necrosectomy for necrotizing pancreatitis,” The New England Journal of Medicine, vol. 362, no. 16, pp. 1491–1502, 2010.